Vivani Medical, Inc.
corporate_fare Company Profile
Vivani Medical, Inc. (NASDAQ:VANI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 30 items for VANI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for VANI spans 10-Q, 8-K, 4, SCHEDULE 13D/A.
Recent high-impact activity:
- Board Members Buy $5.1M of Stock at $1.01 in Insider-Led Private Placement
- Vivani 10-Q: Going Concern Warning, Cash Runway Only Through Q1 2027
- SLIM-1 Data: Semaglutide Implant Matches Wegovy Weight Loss With Zero Treatment-Related AEs
- Vivani Posts $7.3M Q3 Loss, Confirms SLIM-1 Implant Data Due This Week
- Vivani Medical Flags Going Concern, Cash Runs Out by Q2 2027
Financial Snapshot
Short Interest & Short Volume
2.03 days to coverFINRA reported short interest of 369,789 shares in VANI as of the October 30, 2026 settlement, a 11.3% decrease from the prior period — about 2.0 days to cover at its recent average daily volume. On November 20, 2026, 43.2% of VANI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.